Menu
Currency
GWAS Study

Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome wide association analyses.

Mansour A, Mousa M, Abdelmannan D et al.

37033211 PubMed ID
GWAS Study Type
310 Participants
150 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MA
Mansour A
MM
Mousa M
AD
Abdelmannan D
TG
Tay G
HA
Hassoun A
AH
Alsafar H
Chapter II

Abstract

Summary of the research findings

Type 2 diabetes mellitus (T2DM) is a chronic, metabolic disorder in which concomitant insulin resistance and β-cell impairment lead to hyperglycemia, influenced by genetic and environmental factors. T2DM is associated with long-term complications that have contributed to the burden of morbidity and mortality worldwide. The objective of this manuscript is to conduct an Exome-Wide Association Study (EWAS) on T2DM Emirati individuals to improve our understanding on diabetes-related complications to improve early diagnostic methods and treatment strategies.

62 Emirati ancestry cases, 248 Emirati ancestry controls

Chapter III

Study Statistics

Key metrics and study information

310
Total Participants
GWAS
Study Type
No
Replicated
Greater Middle Eastern (Middle Eastern, North African or Persian)
Ancestry
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.